GLP-1 Medications Show Anti-Inflammatory Effects in Psoriasis and Obesity
GLP-1 medications have demonstrated anti-inflammatory effects in patients with psoriasis and obesity. These drugs, commonly used for diabetes, may help reduce inflammation associated with these conditions, offering potential therapeutic benefits beyond blood sugar control. Research highlights their role in improving skin and metabolic health by targeting inflammatory pathways.
Dermatology Times·




